2nd Annual Congress of the European Society for Translational Medicine & Global Network Conference on Translational Medicine (EUSTM-2014)
September 22 - 25, 2014 - Vienna ATEuropean Society for Translational Medicine (EUSTM)
sandra.oberhuber@eutranslationalmedicine.org
Phone:+43 1 8923 562
EUSTM-2014 unites world leaders and experts from industry, academia, research institutions, service providers, SMEs, regulatory agencies, policy makers, and governments to discuss translational approaches and tools designed to accelerate research and develop novel diagnostics and therapeutics thereby reducing high cost budgets and attrition rates. Moreover, EUSTM Expert Panels will discuss and showcase latest developments in specific areas of disease modeling, biomarkers, orphan/rare diseases, clinical epidemiology, novel diagnostics, public health, data management, omics applications and vaccine research. SPECIAL FEATURES: · High Profile Speakers and Panelists including FDA, EMA & NASA · Global Stakeholders and Key Opinion Leaders (KOLs) · Scientific Sessions · Panel Discussions · Featured Symposium - Bexsero (Novartis Vaccines) · New Horizon in Translational Medicine (NHTM) Journal Inauguration Ceremony · Posters Session KEY TOPICS AND THEMES: · Translating Novel Pathophysiological Findings into Therapeutics Developments · New Horizons in Biomarkers & Novel Diagnostics · Novel findings & Updates in Omics Sciences & Data Management · Diseases Modelling: Novel findings & Updates · New Horizons in Vaccine Adjuvants · New Horizons in Orphan Diseases R&D PANEL DISCUSSIONS/SYMPOSIA · Translational approaches to speed up therapeutics developments · Current advancements in modern diagnostic techniques & instrumentations · New Horizons in Orphan Diseases R&D · Disease Modelling- Current situation and future · New Horizons in Vaccine Adjuvants · Emerging role of Microwave Imaging Technology (by EU Cost Action TD1301) FEATURED SPEAKERS: · Elizabeth M. Sutkowski Chief, Regulatory Review Branch 3, DVRPA / OVRR / CBER / FDA (Rockville, Maryland) · Lesley Greene Vice Chair, Committee for Orphan Medicinal Products (COMP), European Medicines Agency (EMA) · Thomas J. Goodwin NASA / Johnson Space Center (Houston, USA) · Sohail Ahmed Global Head of Clinical Sciences, Novartis Vaccines (Italy) · Raffaele Baffa Head of Translational Sciences, ESI, Global BioTherapeutics, SANOFI (Cambridge, USA) · Dimitri Azar Dean, College of Medicine, University of Illinois at Chicago (Chicago, USA) · Giuseppe del Giudice Global Head Translational Medicine, Novartis Vaccines · Joel Haspel Director Product Strategy, Healthcare EMEA, Oracle Health Sciences · Nicolò Manaresi Founder & CSO, Silicon Biosystems, (Bologna Area, Italy) · Nicholas J. Sarlis Vice President & Head of Medical Affairs Incyte Corporation (Philadelphia, USA) WHO WILL SHOWCASE THEIR SERVICES AND PRODUCTS: The conference represents a unique opportunity to showcase and exhibit services & products for following types of companies: - Pharma and biotech - CROs - IT Applications & Software companies - Medtech & medical instruments companies - Molecular Biology & Biochemistry laboratory reagents & services providers - Genomics, Proteomics & Metabolomics services providers - Discover & preclinical services providers - Biomarkers services providers - Data management companies - Clinical services providers - Consultancy firms For more information on sponsorship & exhibition opportunities, please contact: Ms Sandra Oberhuber Event Manager EUSTM-2014 EUSTM Vienna, Austria. sandra.oberhuber@eutranslationalmedicine.org Phone: +43 1 8923 562 Fax: +43 1 8923 562 For conference related inquiries, please contact us at: eustm-2014@eutranslationalmedicine.org Conference Website: www.eutranslationalmedicine.org/eustm-2014